Luye Pharma Reports Stable Share Capital and No Equity Movements in April 2026

Bulletin Express

05/07

For the month ended 30 April 2026, Luye Pharma Group Ltd. reported no changes in either its authorised or issued share capital, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Ltd. on 7 May 2026.

Authorised share capital remained at 10.00 billion ordinary shares with a par value of USD 0.02 each, translating to USD 200.00 million.

Issued share capital was unchanged at 3.99 billion ordinary shares, and the company continued to hold zero treasury shares. As a result, total issued shares outstanding also stayed at 3.99 billion.

Luye Pharma confirmed compliance with the Main Board’s minimum public-float requirement of 25 percent.

Convertible bonds valued at USD 180.00 million (stock code: 05818) were outstanding, carrying a conversion price of HKD 4.88 and equivalent to 288.79 million potential new shares. No conversions took place during the month.

The company reported no share-option exercises, warrant activity, repurchases, or other equity-related transactions in April 2026.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1136842288"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1136842288\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1136842288?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-07 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136842288","market":"hk","top_or_hot":-1,"title":"Luye Pharma Reports Stable Share Capital and No Equity Movements in April 2026","media":"Bulletin Express","content":"<p>For the month ended 30 April 2026, Luye Pharma Group Ltd. reported no changes in either its authorised or issued share capital, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Ltd. on 7 May 2026.</p>\n<p>Authorised share capital remained at 10.00 billion ordinary shares with a par value of USD 0.02 each, translating to USD 200.00 million.</p>\n<p>Issued share capital was unchanged at 3.99 billion ordinary shares, and the company continued to hold zero treasury shares. As a result, total issued shares outstanding also stayed at 3.99 billion.</p>\n<p>Luye Pharma confirmed compliance with the Main Board’s minimum public-float requirement of 25 percent.</p>\n<p>Convertible bonds valued at USD 180.00 million (stock code: 05818) were outstanding, carrying a conversion price of HKD 4.88 and equivalent to 288.79 million potential new shares. No conversions took place during the month.</p>\n<p>The company reported no share-option exercises, warrant activity, repurchases, or other equity-related transactions in April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Luye Pharma Reports Stable Share Capital and No Equity Movements in April 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLuye Pharma Reports Stable Share Capital and No Equity Movements in April 2026\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-05-07 16:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>For the month ended 30 April 2026, Luye Pharma Group Ltd. reported no changes in either its authorised or issued share capital, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Ltd. on 7 May 2026.</p>\n<p>Authorised share capital remained at 10.00 billion ordinary shares with a par value of USD 0.02 each, translating to USD 200.00 million.</p>\n<p>Issued share capital was unchanged at 3.99 billion ordinary shares, and the company continued to hold zero treasury shares. As a result, total issued shares outstanding also stayed at 3.99 billion.</p>\n<p>Luye Pharma confirmed compliance with the Main Board’s minimum public-float requirement of 25 percent.</p>\n<p>Convertible bonds valued at USD 180.00 million (stock code: 05818) were outstanding, carrying a conversion price of HKD 4.88 and equivalent to 288.79 million potential new shares. No conversions took place during the month.</p>\n<p>The company reported no share-option exercises, warrant activity, repurchases, or other equity-related transactions in April 2026.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02186","symbol_name":"綠葉製藥","start_time":0,"source_url":"","article_id":"1136842288","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136842288","pubTimestamp":1778143516,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"For the month ended 30 April 2026, Luye Pharma Group Ltd. reported no changes in either its authorised or issued share capital, according to the company’s monthly return filed with Hong Kong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02186":"绿叶制药"},"translate_title":"绿叶制药2026年4月股本稳定无权益变动","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02186":1},"content_text":"For the month ended 30 April 2026, Luye Pharma Group Ltd. reported no changes in either its authorised or issued share capital, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Ltd. on 7 May 2026.\nAuthorised share capital remained at 10.00 billion ordinary shares with a par value of USD 0.02 each, translating to USD 200.00 million.\nIssued share capital was unchanged at 3.99 billion ordinary shares, and the company continued to hold zero treasury shares. As a result, total issued shares outstanding also stayed at 3.99 billion.\nLuye Pharma confirmed compliance with the Main Board’s minimum public-float requirement of 25 percent.\nConvertible bonds valued at USD 180.00 million (stock code: 05818) were outstanding, carrying a conversion price of HKD 4.88 and equivalent to 288.79 million potential new shares. No conversions took place during the month.\nThe company reported no share-option exercises, warrant activity, repurchases, or other equity-related transactions in April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}